title: [Cerebrolysin in the treatment of brain injuries of moderate severity].
abstract: OBJECTIVE
  To assess the efficacy of cerebrolysin in patients with cranial/brain injury of moderate severity.
  
  
  METHODS
  The main group included 30 patients treated with cerebrolysin from the first day of disease, the comparison group included 32 patients matched for age, sex and disease severity.
  
  
  CONCLUSIONS
  Cerebrolysin promoted the early and complete reduction of common symptoms of brain injury as well as autonomic and asthenic disorders, restoration of cognitive functions, normalization of emotional condition, improvement of spontaneous bioelectrical activity. The drug was well-tolerated.
authors.forename: A E
authors.initials: AE
authors.lastname: Talypov
authors.forename: M Yu
authors.initials: MY
authors.lastname: Myachin
authors.forename: N S
authors.initials: NS
authors.lastname: Kuksova
authors.forename: A Yu
authors.initials: AY
authors.lastname: Kordonsky
mesh_terms: D000328:Adult; D000596:Amino Acids / Q000009:adverse effects / Q000627:therapeutic use*; D001930:Brain Injuries / Q000188:drug therapy*; D003071:Cognition; D004569:Electroencephalography; D004644:Emotions; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D018696:Neuroprotective Agents / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D000596:Amino Acids; D018696:Neuroprotective Agents; C006952:cerebrolysin